NL7708375A - Werkwijze ter bereiding van farmaceutisch actieve verbindingen. - Google Patents

Werkwijze ter bereiding van farmaceutisch actieve verbindingen.

Info

Publication number
NL7708375A
NL7708375A NL7708375A NL7708375A NL7708375A NL 7708375 A NL7708375 A NL 7708375A NL 7708375 A NL7708375 A NL 7708375A NL 7708375 A NL7708375 A NL 7708375A NL 7708375 A NL7708375 A NL 7708375A
Authority
NL
Netherlands
Prior art keywords
active compounds
pharmaceutically active
preparing pharmaceutically
preparing
compounds
Prior art date
Application number
NL7708375A
Other languages
English (en)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NL7708375A publication Critical patent/NL7708375A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7708375A 1976-07-28 1977-07-28 Werkwijze ter bereiding van farmaceutisch actieve verbindingen. NL7708375A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3139176 1976-07-28

Publications (1)

Publication Number Publication Date
NL7708375A true NL7708375A (nl) 1978-01-31

Family

ID=10322405

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7708375A NL7708375A (nl) 1976-07-28 1977-07-28 Werkwijze ter bereiding van farmaceutisch actieve verbindingen.

Country Status (15)

Country Link
JP (1) JPS5315370A (nl)
AU (1) AU2734677A (nl)
BE (1) BE857218A (nl)
CA (1) CA1070315A (nl)
DE (1) DE2733953A1 (nl)
DK (1) DK331877A (nl)
ES (1) ES461100A2 (nl)
FI (1) FI772293A (nl)
FR (1) FR2359840A1 (nl)
IL (1) IL52544A0 (nl)
LU (1) LU77845A1 (nl)
NL (1) NL7708375A (nl)
NO (1) NO772668L (nl)
PL (1) PL107847B1 (nl)
ZA (1) ZA774552B (nl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309435A (en) * 1978-10-16 1982-01-05 Imperial Chemical Industries Ltd. Antisecretory guanidine derivatives and pharmaceutical compositions containing them
FR2446829A1 (fr) 1978-11-16 1980-08-14 Glaxo Group Ltd Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Also Published As

Publication number Publication date
PL199908A1 (pl) 1978-11-20
AU2734677A (en) 1979-02-01
DE2733953A1 (de) 1978-02-02
DK331877A (da) 1978-01-29
FI772293A (nl) 1978-01-29
PL107847B1 (pl) 1980-03-31
FR2359840A1 (fr) 1978-02-24
ZA774552B (en) 1978-06-28
JPS5315370A (en) 1978-02-13
LU77845A1 (nl) 1977-10-25
ES461100A2 (es) 1978-12-01
IL52544A0 (en) 1977-10-31
CA1070315A (en) 1980-01-22
BE857218A (fr) 1978-01-27
NO772668L (no) 1978-01-31

Similar Documents

Publication Publication Date Title
NL7703514A (nl) Werkwijze ter bereiding van triazolopyrimidinen.
NL7709107A (nl) Werkwijze ter bereiding van polyurethanurea.
NL7702726A (nl) Werkwijze ter bereiding van xylitol.
NL7706948A (nl) Werkwijze ter bereiding van muramyldipeptide- -derivaten.
NL7707467A (nl) Werkwijze ter bereiding van hexahydrodibenzo- pyranonverbindingen.
NL7702957A (nl) Werkwijze ter bereiding van stikstofhoudende verbindingen.
NL7710678A (nl) Werkwijze ter bereiding van arylsulfoniumzouten.
NL188748C (nl) Werkwijze ter bereiding van isobuteen.
NL7707128A (nl) Werkwijze ter bereiding van 4-hydrocyfenyl- alkanolaminederivaten.
NL7701128A (nl) Werkwijze ter bereiding van meta-aryloxy- -benzaldehyden.
NL7702169A (nl) Werkwijze ter bereiding van poly-n-butenen.
NL186692C (nl) Werkwijze ter bereiding van pent-3-eenzuur.
NL7709055A (nl) Werkwijze ter bereiding van 3-chloorcefalosporine- derivaten.
NL7704030A (nl) Werkwijze ter bereiding van bis-quartaire pyridinium-2-aldoxime-zouten.
NL7603064A (nl) Werkwijze ter bereiding van stabiele doserings- vormen.
NL7700116A (nl) Werkwijze ter bereiding van prostaglandine-ana- loga.
NL7707200A (nl) Werkwijze ter bereiding van cyclopentaanderi- vaten.
NL7700114A (nl) Werkwijze ter bereiding van prostaglandine-ana- loga.
NL7705086A (nl) Werkwijze ter bereiding van smeltplakmiddelen.
NL7706471A (nl) Werkwijze ter bereiding van optisch actieve an- tracyclinonen.
NL7703541A (nl) Werkwijze ter bereiding van uracilverbindingen.
NL7708375A (nl) Werkwijze ter bereiding van farmaceutisch actieve verbindingen.
NL7605745A (nl) Werkwijze ter bereiding van stabiele oplossingen.
NL7712163A (nl) Werkwijze ter bereiding van 3-acylaminoazetidine 2-onen.
NL187630C (nl) Werkwijze ter bereiding van benzazocinederivaten.

Legal Events

Date Code Title Description
BV The patent application has lapsed